BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2551693)

  • 1. Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.
    Manandhar DS; Sarkawi S; Hunt MC
    Eur J Pediatr; 1989 Aug; 148(8):761-3. PubMed ID: 2551693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia in vitamin D-dependent rickets type II responding to 1α-hydroxycholecalciferol.
    Kumar V; Kumar M; Yadav M
    Ann Trop Paediatr; 2010; 30(4):329-33. PubMed ID: 21118628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy.
    Silver J; Landau H; Bab I; Shvil Y; Friedlaender MM; Rubinger D; Popovtzer MM
    Isr J Med Sci; 1985 Jan; 21(1):53-6. PubMed ID: 2982764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Administration of phosphates and 1 alpha-hydroxyvitamin D3 during the postoperative immobilization of children with familial hypophosphatemic rickets].
    Pronicka E; Wieczorek E; Kulczycka H; Rowińska E; Tylman D; Pomierna I; Fijałkowski S
    Pol Tyg Lek; 1985 Sep; 40(35):992-6. PubMed ID: 4070045
    [No Abstract]   [Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-organ resistance to 1,25-dihydroxycholecalciferol.
    Liberman UA; Samuel R; Halabe A; Kauli R; Edelstein S; Weisman Y; Papapoulos SE; Clemens TL; Fraher LJ; O'Riordan JL
    Lancet; 1980 Mar; 1(8167):504-6. PubMed ID: 6102232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.
    Tsuchiya Y; Matsuo N; Cho H; Kumagai M; Yasaka A; Suda T; Orimo H; Shiraki M
    J Clin Endocrinol Metab; 1980 Oct; 51(4):685-90. PubMed ID: 6252222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphatemic vitamin D resistant rickets treatment with one alpha hydroxy vitamin D3.
    Tragler A; Pai BU
    Indian Pediatr; 1989 Apr; 26(4):386-8. PubMed ID: 2557284
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
    Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
    Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
    Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
    Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case of vitamin D resistant rickets with hypophosphatemia treated with 25OHD3].
    Minerva Pediatr; 1977 Dec; 29(39):2407-9. PubMed ID: 202857
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcitriol-resistant rickets with alopecia.
    Hochberg Z; Gilhar A; Haim S; Friedman-Birnbaum R; Levy J; Benderly A
    Arch Dermatol; 1985 May; 121(5):646-7. PubMed ID: 2986561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.